I agree that this site is using cookies. You can find further informations here.
X
Augustijns, P.
93  results:
Search for persons X
?
1

Effect Of Food Intake On Gastrointestinal Transit, Pressure..:

Steenackers, N. ; Wauters, L. ; Van der Schueren, B....
Clinical Nutrition ESPEN.  54 (2023)  - p. 650 , 2023
Link: https://doi.org/10.1016/..
 
?
2

UNGAP best practice for improving solubility data quality o..:

Vertzoni, M ; Alsenz, J ; Augustijns, P...
European Journal of Pharmaceutical Sciences.  168 (2022)  - p. 106043 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Fasted and fed state human duodenal fluids: Characterizatio..:

Dahlgren, D. ; Venczel, M. ; Ridoux, J.-P....
European Journal of Pharmaceutics and Biopharmaceutics.  163 (2021)  - p. 240-251 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Effect of obesity on gastrointestinal transit, pressure and..:

Steenackers, N. ; Wauters, L. ; Van der Schueren, B....
European Journal of Pharmaceutics and Biopharmaceutics.  167 (2021)  - p. 1-8 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Six years of progress in the oral biopharmaceutics area – A..:

Abrahamsson, B. ; McAllister, M. ; Augustijns, P....
European Journal of Pharmaceutics and Biopharmaceutics.  152 (2020)  - p. 236-247 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Introduction to the OrBiTo decision tree to select the most..:

Andreas, C.J. ; Rosenberger, J. ; Butler, J....
European Journal of Pharmaceutics and Biopharmaceutics.  130 (2018)  - p. 207-213 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Opening the black box: Gastric motility, as assessed by the..:

Goelen, N. ; Morales, J. ; Varon, C....
Clinical Nutrition.  37 (2018)  - p. S34 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Evaluation of real-life dosing of oral medicines with respe..:

Hens, B. ; Van Den Abeele, J. ; Rubbens, J....
Journal of Clinical Pharmacy and Therapeutics.  42 (2017)  4 - p. 467-474 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Verapamil hepatic clearance in four preclinical rat models:..:

Nicolaï, J. ; De Bruyn, T. ; Van Veldhoven, P. P....
Biopharmaceutics & Drug Disposition.  36 (2015)  7 - p. 462-480 , 2015
Link: https://doi.org/10.1002/..
 
?
10

Oral biopharmaceutics tools – Time for a new initiative – A..:

Lennernäs, H. ; Aarons, L. ; Augustijns, P....
European Journal of Pharmaceutical Sciences.  57 (2014)  - p. 292-299 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Solubilizing agents in nasal formulations and their effect ..:

Vetter, A. ; Augustijns, P. ; Bernkop-Schnürch, A.
Toxicology in Vitro.  26 (2012)  1 - p. 150-156 , 2012
Link: https://doi.org/10.1016/..
 
?
12

Influence of the composition of in-vitro azo-reducing syste..:

Maris, B ; Verheyden, L ; Samyn, C...
Journal of Pharmacy and Pharmacology.  54 (2010)  2 - p. 197-203 , 2010
Link: https://doi.org/10.1211/..
 
?
13

Potential of amorphous microporous silica for ibuprofen con..:

Aerts, C.A. ; Verraedt, E. ; Depla, A....
International Journal of Pharmaceutics.  397 (2010)  1-2 - p. 84-91 , 2010
Link: https://doi.org/10.1016/..
 
?
14

Postprandial Evolution in Composition and Characteristics o..:

Clarysse, S. ; Tack, J. ; Lammert, F....
Journal of Pharmaceutical Sciences.  98 (2009)  3 - p. 1177-1192 , 2009
Link: https://doi.org/10.1002/..
 
?
15

A step further in the SATE mononucleotide prodrug approach:

Peyrottes, S. ; Villard, A.-L. ; Coussot, G....
Nucleic Acids Symposium Series.  52 (2008)  1 - p. 539-540 , 2008
Link: https://doi.org/10.1093/..
 
1-15